by Denver Frederick | Sep 10, 2019 | Guest Interview
Cancer will soon be the No.1 killer in America, and playing it safe when it comes to funding research is not going to change that. Rather, we need to fund the brave, the bold, and the best, and that is what the Damon Runyon Cancer Research Foundation has been doing since 1946. And here to tell us about their strategy and impact is Dr. Yung Lie, the President and CEO of the Damon Runyon Cancer Research Foundation.
by Denver Frederick | Apr 23, 2018 | Better Than Most
And this evening, you’ll be visiting one of the most highly respected and important organizations in the country. It is the American Cancer Society, founded back in 1913. We’ll begin the segment with their Chief Executive Officer, Gary Reedy. And then hear from the other members of a very dedicated and passionate team.
by Denver Frederick | Nov 29, 2017 | Guest Interview
Livestrong, the cancer group founded by Lance Armstrong, has certainly been through a tumultuous period. As a result of the doping and performance-enhancing drug scandal that engulfed its founder, the organization saw its revenues fall from $46 million in 2011 to $6.2 million in 2015. But Livestrong has proven to be resilient, and revenues are slowly making their way back up, and its essential work continues. And this is all being led by my next guest. He is Greg Lee, the President and CEO of the Livestrong Foundation.
by Denver Frederick | Jul 19, 2017 | Guest Interview
Nearly 40% of men and women will be diagnosed with cancer at some point in their lifetimes, and I dare say that not a single person listening has not been personally impacted by this disease. Leading the fight against cancer in the United States for over a century now has been the American Cancer Society, but it is also an organization that has reinvented and reimagined itself for the modern era. And with us this evening is a key architect of that transformation. He is Gary Reedy, the President and CEO of the American Cancer Society.
by Denver Frederick | Jun 19, 2016 | Guest Interview
The Leukemia & Lymphoma Society raises more than $300 million a year with an average donation of just $75. Amassing that huge network of grass-roots backers has helped the New York State-based charity pump more than $1 billion into research that has “led to the discovery of virtually every modern therapy used to treat the blood cancers,” says Louis DeGennaro, the society’s chief executive officer. Blood cancers are the third-leading cause of U.S. cancer deaths.
